BIOMAT Database Logo BIOMAT Database Logo

Salt intake and blood pressure response to percutaneous renal denervation in resistant hypertension. 2017

Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.

The effect of lowering sympathetic nerve activity by renal denervation (RDN) is highly variable. With the exception of office systolic blood pressure (BP), predictors of the BP-lowering effect have not been identified. Because dietary sodium intake influences sympathetic drive, and, conversely, sympathetic activity influences salt sensitivity in hypertension, we investigated 24-hour urinary sodium excretion in participants of the SYMPATHY trial. SYMPATHY investigated RDN in patients with resistant hypertension. Both 24-hour ambulatory and office BP measurements were end points. No relationship was found for baseline sodium excretion and change in BP 6 months after RDN in multivariable-adjusted regression analysis. Change in the salt intake-measured BP relationships at 6 months vs baseline was used as a measure for salt sensitivity. BP was 8 mm Hg lower with similar salt intake after RDN, suggesting a decrease in salt sensitivity. However, the change was similar in the control group, and thus not attributable to RDN.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Resistant hypertension: multivariate predictors of blood pressure response to renal denervation.
October 2013, International journal of cardiology,
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
January 2016, International journal of cardiology,
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
May 2017, Clinical research in cardiology : official journal of the German Cardiac Society,
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Erratum to: Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
May 2017, Clinical research in cardiology : official journal of the German Cardiac Society,
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Reduced Renal Mass, Salt-Sensitive Hypertension Is Resistant to Renal Denervation.
January 2018, Frontiers in physiology,
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
August 2017, Journal of the American Heart Association,
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Impressive blood pressure and heart rate response after percutaneous renal denervation in a woman with morbid obesity and severe drug-resistant hypertension.
November 2013, Journal of clinical hypertension (Greenwich, Conn.),
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".
May 2014, Circulation,
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
July 2013, Circulation,
Esther de Beus, and Rosa L de Jager, and Martine M Beeftink, and Margreet F Sanders, and Wilko Spiering, and Evert-Jan Vonken, and Michiel Voskuil, and Michiel L Bots, and Peter J Blankestijn, and
Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
September 2013, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!